 |
 |
 |
 |
 |
 |
 |
 |
 |  | Drug discovery and development utilizing pioneering G-protein coupled receptor (GPCR) technology
|  | Private
|  | 2009
|
 |
 |  | Developing the first generation of nanoparticle immunomodulatory drugs
|  | Private
|  | 2008
|
 |
 |  | Developing novel drugs targeting cancer metabolism
|  | Private
|  | 2008
|
 |
 |  | Developing therapeutic targeted nanoparticles
|  | Private
|  | 2007
|
 |
 |  | Developing new medicines utilizing deuterium
|  | Private
|  | 2006
|
 |
 |  | Developing novel antibiotics to treat drug-resistant infections
|  | Private
|  | 2006
|
 |
 |  | Developing new treatments for celiac disease
|  | Private
|  | 2006
|
 |
 |  | Developing therapeutics for inflammatory diseases utlizing resolvins
|  | Private
|  | 2006
|
 |
 |  | Developing drugs to treat musculoskeletal and metabolic disorders, and cancer-related diseases
|  | Private
|  | 2004
|
 |
 |  | Developing platform to synthesize compounds for drug discovery and biodetection
|  | Private
|  | 2004
|
 |
 |  | Developing cell-based therapies that induce repair and regeneration in a wide array of tissues
|  | Private
|  | 2003
|
 |
 |  | Developing novel, targeted cancer therapeutics
|  | Private
|  | 2003
|
 |
 |  | Developing novel kinase inhibitors to treat cancer, autoimmune, and inflammatory diseases
|  | Private
|  | 2001
|
 |